Clinical practice guideline suggests using GLP-1 receptor agonists to manage obesity in women planning pregnancy, indicating potential health benefits.
M.A.W. has received speaker honoraria from the American Board of Obesity Medicine, the Endocrine Society, Weill Cornell, and St. John's hospital and served as a co-chair of the Endocrine Society Clinical Practice Guideline.
No takes yet. Share an insight, caveat, or question.
Berube et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: